(Q58576729)

English

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol

scientific article published on 8 November 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

0 references

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

0 references

1 reference

based on heuristic

inferred from title

Nafeesa N Dhalwani

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Humaira Hussein

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

5

object named as

Kamlesh Khunti

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

author name string

Francesco Zaccardi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Laura J Gray

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

language of work or name

0 references

publication date

8 November 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

e023206

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graphical tools for network meta-analysis in STATA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological aspects of the safety of gliflozins.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular Safety, Long-Term Noncardiovascular Safety, and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis With Trial Sequential Analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30413509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJOPEN-2018-023206

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30413509%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58576729&oldid=1925134235"